A

Avalon BioVentures

4 employees

Avalon BioVentures operates as a biotech venture capital firm.

Investor insights

Sectors invested in

Medical1
Therapeutics1
Health Care1

Funding rounds participated in

$58M sweet spot round size

Most of their 1 investments are in rounds between $58M and $58M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Date founded

2013

Investments made

A

Arialys Therapeutics, Inc. raised $58M on September 12, 2023

Investors: MPM Capital, Catalys Pacific and Avalon BioVentures

FAQ